PSC
CNMD icon

Portman Square Capital’s CONMED CNMD Stock Holding History

Portman Square Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75,000
Closed -$3.91M – 122
2025
Q2 		$3.91M Sell
75,000
-75,400
-50% -$4.14M 0.11% 141
2025
Q1 		$9.08M Buy
150,400
+40,000
+36% +$2.58M 0.24% 115
2024
Q4 		$7.56M Buy
110,400
+33,200
+43% +$2.31M 0.27% 87
2024
Q3 		$5.55M Buy
+77,200
New +$5.45M 0.21% 140

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Portman Square Capital's CNMD Position: Q1 2025 in Review

Portman Square Capital sold out of CONMED (CNMD) in Q1 2025, closing a stake of 15,640 shares — an estimated $1.01M sold.

Portman Square Capital first reported a position in CNMD in Q4 2022 and held it in 7 quarters. The position peaked at $3.37M in Q2 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • Portman Square Capital reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • Portman Square Capital sold 15,640 CONMED shares in Q1 2025, an estimated $1.01M.
  • Portman Square Capital first reported a position in CONMED in Q4 2022 and held it in 7 quarters.
  • Portman Square Capital's CONMED position peaked at $3.37M in Q2 2023.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Portman Square Capital's 13F filing for Q1 2025, filed 2 May 2025.